Thyroxine Treatment During the Perinatal Stage Prevents the Alterations in the ObRb-STAT3 Leptin Signaling Pathway Caused by Congenital Hypothyroidism
In conclusion, thyroxine treatment during the critical
perinatal stage for metabolic programming prevents congenital
hypothyroidism-caused metabolic syndrome and hypothalamic leptin resistance. [...] © Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals: Table of contents | Abstract | Full text
Source: Hormone and Metabolic Research - Category: Endocrinology Authors: Tapia-Mart ínez, Jorge Cano-Europa, Edgar Blas-Valdivia, Vanessa Franco-Col ín, Margarita Tags: Endocrine Research Source Type: research
More News: Cardiology | Cardiovascular | Endocrinology | Heart | Hormones | Hypothyroidism | Insulin | Metabolic Syndrome | Perinatology & Neonatology | Pregnancy | Study